
|Articles|September 23, 2009
StudyManager Expands into China
Advertisement
“China is the next logical step for us,” said Bruce Schatzman, Founder and Chief Executive Officer of StudyManager. “Because the cost of paper trials in China is still very competitive, we believe our EDC solution is a great choice when Chinese CROs and sponsors don’t see the price/performance value offered by larger EDC providers.”
To accomadate Asian expansion, StudyManager opened a data center in Shanghai, from which Chinese companies can run its EDC/CTMS system in what it calls "a secure and compliant manner."
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
The Evolution of Preclinical CRO Strategic Partnerships: From Transactional Services to Value-Driven Ecosystems in 2026
2
The Execution Gap: Why Clinical Trial Infrastructure Has to Be Built Before AI Can Deliver
3
Operationalizing the Patient Voice: Converging U.S., EU, and UK Requirements and the Role of Real-World Patient-Reported Data
4
How Clinical Teams Can Build Real Trust With Patient Advocacy Organizations
5




